| claim |
ai-alignment |
The EU deferred AI Act Omnibus enforcement while the US issued the Hegseth mandate removing safety constraints, both occurring November 2025-May 2026 through opposite mechanisms but producing identical outcomes |
experimental |
Theseus synthetic analysis across Sessions 39-40, EU AI Act Omnibus deferral, Hegseth mandate |
2026-05-01 |
EU and US AI governance retreats converged cross-jurisdictionally in the same 6-month window despite opposite regulatory traditions suggesting structural rather than politically contingent drivers |
theseus |
ai-alignment/2026-05-01-theseus-b1-eight-session-robustness-eu-us-parallel-retreat.md |
structural |
Theseus |
| government-designation-of-safety-conscious-AI-labs-as-supply-chain-risks-inverts-the-regulatory-dynamic-by-penalizing-safety-constraints-rather-than-enforcing-them |
|
| only-binding-regulation-with-enforcement-teeth-changes-frontier-ai-lab-behavior-because-every-voluntary-commitment-has-been-eroded-abandoned-or-made-conditional-on-competitor-behavior-when-commercially-inconvenient |
|
| voluntary-safety-constraints-without-enforcement-are-statements-of-intent-not-binding-governance |
| only-binding-regulation-with-enforcement-teeth-changes-frontier-ai-lab-behavior-because-every-voluntary-commitment-has-been-eroded-abandoned-or-made-conditional-on-competitor-behavior-when-commercially-inconvenient |
| government-designation-of-safety-conscious-AI-labs-as-supply-chain-risks-inverts-the-regulatory-dynamic-by-penalizing-safety-constraints-rather-than-enforcing-them |
| cross-jurisdictional-governance-retreat-convergence-indicates-regulatory-tradition-independent-pressures |
| pre-enforcement-governance-retreat-removes-mandatory-ai-constraints-through-legislative-deferral-before-testing |
| eu-ai-governance-reveals-form-substance-divergence-at-domestic-regulatory-level-through-simultaneous-treaty-ratification-and-compliance-delay |
| eu-ai-act-article-2-3-national-security-exclusion-confirms-legislative-ceiling-is-cross-jurisdictional |
| regulatory-rollback-clinical-ai-eu-us-2025-2026-removes-high-risk-oversight-despite-accumulating-failure-evidence |
|